Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Neurotoxicol Teratol. 2020 Apr 11;79:106883. doi: 10.1016/j.ntt.2020.106883

Figs. 7A-D. MWM hidden platform phases (long-term, dose-response study).

Figs. 7A-D.

There no differences in the Acquisition and Reverse phases based on sex or treatment. There was a significant sex x treatment interaction in the Shift-reduced phase with both groups of taurine-treated males having significantly shorter path lengths compared with control males on Days 5-6. In contrast, taurine-treated females had significantly longer path lengths compared with control females. * P < 0.05.